Could toll‐like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue

In the last decade the development of a number of biological therapies has revolutionised the treatment of rheumatic diseases. The first and most widely used of these approaches, tumour necrosis factor (TNF) blockade (infliximab, entanercept, adalimumab), has now been administered to over a million...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sacre, Sandra M, Drexler, Stefan K, Andreakos, Evangelos, Feldmann, Marc, Brennan, Fionula M, Foxwell, Brian M J
Format: Artigo
Langue:Inglês
Publié: BMJ Group 2007
Sujets:
Supplement
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2095278/
https://ncbi.nlm.nih.gov/pubmed/17934103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.079012
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires